PomDoctor Limited (POM)
PomDoctor will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
PomDoctor Statistics
Total Valuation
Market Cap | n/a |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | $292,353 |
Profits Per Employee | -$123,333 |
Employee Count | 154 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PomDoctor had revenue of $45.02 million and -$18.99 million in losses.
Revenue | 45.02M |
Gross Profit | 6.05M |
Operating Income | -2.56M |
Pretax Income | -19.21M |
Net Income | -18.99M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $1.94 million in cash and $65.90 million in debt, giving a net cash position of -$63.96 million.
Cash & Cash Equivalents | 1.94M |
Total Debt | 65.90M |
Net Cash | -63.96M |
Net Cash Per Share | n/a |
Equity (Book Value) | -304.35M |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -$3.76 million and capital expenditures -$18,058, giving a free cash flow of -$3.78 million.
Operating Cash Flow | -3.76M |
Capital Expenditures | -18,058 |
Free Cash Flow | -3.78M |
FCF Per Share | n/a |
Margins
Gross margin is 13.45%, with operating and profit margins of -5.69% and -42.19%.
Gross Margin | 13.45% |
Operating Margin | -5.69% |
Pretax Margin | -42.67% |
Profit Margin | -42.19% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -8.40% |
Dividends & Yields
PomDoctor does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |